G Musso, A Sircana, F Saba,
M Cassader… - PLoS …, 2020 - journals.plos.org
Background Sodium-glucose cotransporter-2 (SGLT2) inhibitors (SGLT2i) showed benefits
in type 1 diabetes mellitus (T1DM), but the risk of diabetic ketoacidosis (DKA) limits their use …